Search all trials

Find therapies in clinical trials near you – page 9

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Influenza+1

Recruiting

Registered drugNo placebo

Efficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years

Registered drugNo placebo

Germany

Participants:65+ years · Healthy volunteers
Substances:INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED

Contact Research Centre

Small cell lung cancer extensive stage

Recruiting

Registered drugNo placebo

Phase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Siltuximab

Contact Research Centre

Type 2 diabetes mellitus

Recruiting

Registered drug

Efficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Semaglutide

Contact Research Centre

Gastrointestinal stromal tumour

Recruiting

InvestigationalNo placebo

Phase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Imatinib Mesilate

Contact Research Centre

Lipoprotein (a) increased

Recruiting

Investigational

Phase 2 study of MK-7262 and enlicitide decanoate in adults with high lipoprotein(a)

Investigational

Germany

Participants:18–64 years · 65+ years

Contact Research Centre

Dementia Alzheimer's type

Recruiting

Investigational

A study of SAR448851 with FLORQUINITAU (18F) to assess safety and effectiveness in early Alzheimer’s disease

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Florquinitau (18F)

Contact Research Centre

Hypercholesterolaemia

Recruiting

Investigational

Laroprovstat/rosuvastatin versus rosuvastatin for lowering LDL‑C in patients with high cholesterol

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Rosuvastatin

Contact Research Centre

Breast cancer+1

Recruiting

Registered drugNo placebo

Evaluation of zongertinib, fulvestrant and goserelin acetate in patients with HR‑positive HER2‑negative advanced breast cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Fulvestrant

Contact Research Centre

Colitis ulcerative

Recruiting

InvestigationalNo placebo

Efficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Golimumab

Contact Research Centre

Type 2 diabetes mellitus

Recruiting

Registered drug

A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Azd5004

Contact Research Centre

Type 2 diabetes mellitus

Recruiting

Registered drug

Randomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Azd5004

Contact Research Centre

Systemic scleroderma

Recruiting

Investigational

A double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Bi 1015550

Contact Research Centre

Find therapies in clinical trials near you – page 9

1 766 trials match your criteria

Influenza+1

Efficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years

Small cell lung cancer extensive stage

Phase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy

Type 2 diabetes mellitus

Efficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes

Gastrointestinal stromal tumour

Phase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)

Lipoprotein (a) increased

Phase 2 study of MK-7262 and enlicitide decanoate in adults with high lipoprotein(a)

Dementia Alzheimer's type

A study of SAR448851 with FLORQUINITAU (18F) to assess safety and effectiveness in early Alzheimer’s disease

Hypercholesterolaemia

Laroprovstat/rosuvastatin versus rosuvastatin for lowering LDL‑C in patients with high cholesterol

Breast cancer+1

Evaluation of zongertinib, fulvestrant and goserelin acetate in patients with HR‑positive HER2‑negative advanced breast cancer

Colitis ulcerative

Efficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis

Type 2 diabetes mellitus

A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

Type 2 diabetes mellitus

Randomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function

Systemic scleroderma

A double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.